Study Finds Inavolisib Combination Treatment Improved PFS in Patients With Breast Cancer
December 5th 2023In the first-line setting, inavolisib plus palbociclib and fulvestrant improved PFS in patients with HR-positive breast cancers; however, further research is needed to understand the trends in OS.
Read More
FDA Grants 510(k) Clearance for CARE Oral Appliances to Treat Adults with Severe OSA
November 29th 2023This FDA clearance comes about 11 months after another clearance for appliances to treat mild-to-moderate obstructive sleep apnea (OSA)—the first clearance for oral appliances to treat OSA with supplemental therapies.
Read More
Combination Prevention Efforts Significant in Reducing HIV Incidence, But Further Action Necessary
November 29th 2023Combination prevention strategies reduced the number of new HIV infections among gay and bisexual men who have sex with men; however, improvement of current methods is needed to meet the 2025 and 2030 reduction goals.
Read More